Apnea study

About this study

Prevalence rates for sleep apnea syndrome (SAS) are reported to range from 10% to 40% in the general population. The most prescribed therapy, positive airway pressure, which has proven efficacy, has an adherence rate of about 50% and was expensive. In addition, recent studies suggest that about 40 – 60% of patients with diagnosed SAS also report insomnia symptoms. This association has raised the possibility that comorbid insomnia or sleep disruption may have an important negative impact on the success of obstructive sleep apnea treatment. In this context, new alternative therapies must be studied, in particular in the patients suffering from both SAS and insomnia.

In this view, the goal of this work is to study cognitive-behavioral therapy and exercise training intervention among insomnia patients with comorbid SAS.